Commentary · 26 Dec 2023
Short communicationPublished Jan 2021
Natural killer cell based immunotherapies as cancer therapeutics
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Natural killer (NK) cells are known to target cancer cells. Since conventional cancer therapeutics including chemotherapy and radiotherapy remain unsuccessful to completely cure the cancer, there has been increasing demand of immunotherapies to treat cancer. In past few years there has been NK cell-based immunotherapies showed promising results. But, decreased NK cell cytotoxicity has been documented in cancer patients both in peripheral blood and tumour microenvironment. Advances in understanding of anti-tumour immune responses and cancer biology have revealed a complex dynamic interaction between the immune effectors and the tumour cells. Therefore, because of defects in cancer patients’ NK cells, utilizing healthy allogeneic NK cells should be selected as cancer immunotherapeutic.
Subjects
MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medical Microbiology Reports.
Short communication · 26 Dec 2023
Managing the Obstacles and Advances of Virological Analysis
Opinion · 26 Dec 2023
Exploring Morphological Diversity in the Natural World
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedical Microbiology Reports
- SubjectMicrobiology
- BylineArticles whose byline prints “Kawaljit Kaur”
